BN Business News
Bedrijf toevoegen →
Deze vertaling wordt voorbereid. Voorlopig tonen we de oorspronkelijke Engelse versie.

Bedrijven · 12-6-20141 min lezen

Determination of Regulatory Review Period for Purposes of Patent Extension; Arctic Front Cryocatheter System

Lokale automatische vertaling · Oorspronkelijke brontaal

Samenvatting

The Food and Drug Administration (FDA) has determined the regulatory review period for Arctic Front Cryocatheter System and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of Patents and Trademarks, Department of Commerce, for the extension of patents which claim that medical device.

Oorspronkelijke brontaal: Federal Register — Food and Drug AdministrationOrigineel bericht openen →